Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from MedAdvisor Limited ( (AU:MDR) ).
MedAdvisor Limited, a company in the healthcare technology sector, is known for its digital medication management solutions. Recently, Mercer Investments (Australia) Limited, acting as the responsible entity of the Mercer Australian Small Companies Fund, has ceased to be a substantial holder in MedAdvisor Limited as of May 16, 2025. This change involved the sale of 2,565,351 shares, potentially impacting MedAdvisor’s shareholder structure and market perception.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.21 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
Average Trading Volume: 823,713
Technical Sentiment Signal: Sell
Current Market Cap: A$54.32M
For detailed information about MDR stock, go to TipRanks’ Stock Analysis page.